All Type of News
Serious Adverse Effect of Benzbromarone Re-Emphasized
The Korea Food and Drug Administration (KFDA) recently released an advisory letter addressed to the healthcare professionals on the reported mortality instances in Japan by medications containing benzbromarone, which ...
Green Cross Appoints New Chief Technology Officer
Green Cross announced the appointment of Dr. Chang Jong-whan as Chief Technology Officer (CTO) and Vice President of the company on January 10th.
Prior to the appointment, Dr. Chang served as the director of resear...
Government Permits 17 Domestic Human Tissue Banks
The Korea Food and Drug Administration (KFDA) gave its final approvals on January 7th of the operational permits to 17 domestic human tissue banks, in an effort to promote the activities surrounding the human tissue d...
KFDA Concentrates on Top 300 Pharmaceutical Items for Quality Inspection
Under an initiative to conduct quality inspections on 2,000 pharmaceutical items for the current year, the Korea Food and Drug Administration (KFDA) announced it would concentrate on the top 300 items, in terms of the...
Pfizer Korea Defends Reported Market Share Decline of Novarsc
Pfizer Korea defends its position on the reported sharp decline in the domestic market share of Novarsc, by stating that the individual claims on the substitution rates of the original product made by its competing ge...
Local Wholesalers Stress on Consolidation Efforts
Under the worsening financial situations collectively experienced by the domestic pharmaceutical wholesalers, the consensus among them to bring out a significant level of consolidation efforts to minimize costly compe...
Iressa Proven for Extended Survival Rates among Asians
AstraZeneca Korea recently announced the results from the first-level intermediate analysis of ISEL (Iressa Survival Evaluation in Lung cancer) Study, an international clinical trial conducted against 1,692 patients w...
Existing NHI Claim Policy under Debate
The pharmaceutical industry is debating over the existing insurance claim policy governing the use of actual transaction prices in the National Health Insurance (NHI) claims made by the healthcare providers, where the...
Practical Learning Opportunities for Pharmacy Students via Co-op Program
A local university recently announced that it is providing its students majoring in pharmacy an on-site learning opportunity to experience the actual business undertaking of pharmaceutical R&D and manufacturing activi...
KFDA Attempts to Bring Out Industry-Wide Understanding on DMF Requirements
Reflecting the government's effort to implement the Pharmaceutical Bulk Report System scheduled by September of this year, the Korea Food and Drug Administration (KFDA) will host a meeting on January 12th to provide d...
